Crescent Grove Advisors LLC Sells 5,006 Shares of SPDR S&P Biotech ETF $XBI

Crescent Grove Advisors LLC cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 67,024 shares of the exchange traded fund’s stock after selling 5,006 shares during the quarter. SPDR S&P Biotech ETF makes up about 0.8% of Crescent Grove Advisors LLC’s holdings, making the stock its 29th biggest position. Crescent Grove Advisors LLC owned approximately 0.10% of SPDR S&P Biotech ETF worth $8,172,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in XBI. China Universal Asset Management Co. Ltd. boosted its stake in SPDR S&P Biotech ETF by 868.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $417,000. Banque Pictet & Cie SA boosted its stake in SPDR S&P Biotech ETF by 24.1% in the fourth quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after acquiring an additional 12,595 shares during the last quarter. Apella Capital LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $490,000. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $1,287,000.

SPDR S&P Biotech ETF Stock Up 1.6%

XBI opened at $129.83 on Thursday. The stock has a market cap of $8.28 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $139.19. The company’s 50-day moving average price is $131.53 and its two-hundred day moving average price is $126.41.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.